Similar differential effects have also been observed in miRNA expression levels following HDAC inhibitor treatment as increases in miRNA expression have been noted in colorectal cancer and lymphoma cell lines, but no changes in miRNA levels were observed following TSA treatment of the A549 lung cancer cell line [44, 131, 132]. This evidence concerns the gene HDAC9 and lung carcinoma.